nodes	percent_of_prediction	percent_of_DWPC	metapath
Eprosartan—ABCC2—bile duct—pancreatitis	0.1	0.465	CbGeAlD
Eprosartan—ABCC2—bile—pancreatitis	0.0768	0.357	CbGeAlD
Eprosartan—Retrosternal pain—Hyoscyamine—pancreatitis	0.0359	0.0724	CcSEcCtD
Eprosartan—Extrasystoles—Hyoscyamine—pancreatitis	0.0172	0.0347	CcSEcCtD
Eprosartan—AGTR1—ACE Inhibitor Pathway—BDKRB2—pancreatitis	0.014	0.0482	CbGpPWpGaD
Eprosartan—ABCC2—ABC-family proteins mediated transport—CFTR—pancreatitis	0.0134	0.0462	CbGpPWpGaD
Eprosartan—Rash maculo-papular—Hyoscyamine—pancreatitis	0.0131	0.0265	CcSEcCtD
Eprosartan—AGTR1—ACE Inhibitor Pathway—KNG1—pancreatitis	0.0127	0.0439	CbGpPWpGaD
Eprosartan—Tension—Propantheline—pancreatitis	0.0121	0.0244	CcSEcCtD
Eprosartan—Nervousness—Propantheline—pancreatitis	0.012	0.0242	CcSEcCtD
Eprosartan—Swelling—Hyoscyamine—pancreatitis	0.0119	0.024	CcSEcCtD
Eprosartan—Eczema—Hyoscyamine—pancreatitis	0.0117	0.0236	CcSEcCtD
Eprosartan—Atrial fibrillation—Hyoscyamine—pancreatitis	0.0111	0.0223	CcSEcCtD
Eprosartan—AGTR1—blood—pancreatitis	0.0111	0.0514	CbGeAlD
Eprosartan—Palpitations—Propantheline—pancreatitis	0.0109	0.022	CcSEcCtD
Eprosartan—Hyponatraemia—Hyoscyamine—pancreatitis	0.0105	0.0213	CcSEcCtD
Eprosartan—Osteoarthritis—Hyoscyamine—pancreatitis	0.0105	0.0212	CcSEcCtD
Eprosartan—Dry mouth—Propantheline—pancreatitis	0.0103	0.0207	CcSEcCtD
Eprosartan—Ataxia—Hyoscyamine—pancreatitis	0.00986	0.0199	CcSEcCtD
Eprosartan—Tachycardia—Propantheline—pancreatitis	0.00982	0.0198	CcSEcCtD
Eprosartan—Hypokalaemia—Hyoscyamine—pancreatitis	0.00954	0.0193	CcSEcCtD
Eprosartan—Insomnia—Propantheline—pancreatitis	0.0091	0.0184	CcSEcCtD
Eprosartan—Somnolence—Propantheline—pancreatitis	0.00895	0.0181	CcSEcCtD
Eprosartan—Angina pectoris—Hyoscyamine—pancreatitis	0.00883	0.0178	CcSEcCtD
Eprosartan—Constipation—Propantheline—pancreatitis	0.00861	0.0174	CcSEcCtD
Eprosartan—ABCC2—digestive system—pancreatitis	0.00839	0.039	CbGeAlD
Eprosartan—Feeling abnormal—Propantheline—pancreatitis	0.00829	0.0168	CcSEcCtD
Eprosartan—Hyperglycaemia—Hyoscyamine—pancreatitis	0.00817	0.0165	CcSEcCtD
Eprosartan—Depression—Hyoscyamine—pancreatitis	0.00806	0.0163	CcSEcCtD
Eprosartan—ABCC2—blood—pancreatitis	0.008	0.0372	CbGeAlD
Eprosartan—Urticaria—Propantheline—pancreatitis	0.008	0.0162	CcSEcCtD
Eprosartan—Conjunctivitis—Hyoscyamine—pancreatitis	0.00785	0.0159	CcSEcCtD
Eprosartan—Hypersensitivity—Propantheline—pancreatitis	0.00742	0.015	CcSEcCtD
Eprosartan—Bradycardia—Hyoscyamine—pancreatitis	0.00738	0.0149	CcSEcCtD
Eprosartan—Asthenia—Propantheline—pancreatitis	0.00722	0.0146	CcSEcCtD
Eprosartan—Dizziness—Propantheline—pancreatitis	0.00666	0.0134	CcSEcCtD
Eprosartan—Vomiting—Propantheline—pancreatitis	0.0064	0.0129	CcSEcCtD
Eprosartan—Rash—Propantheline—pancreatitis	0.00635	0.0128	CcSEcCtD
Eprosartan—Dermatitis—Propantheline—pancreatitis	0.00634	0.0128	CcSEcCtD
Eprosartan—Headache—Propantheline—pancreatitis	0.00631	0.0127	CcSEcCtD
Eprosartan—Tension—Hyoscyamine—pancreatitis	0.0062	0.0125	CcSEcCtD
Eprosartan—Nervousness—Hyoscyamine—pancreatitis	0.00613	0.0124	CcSEcCtD
Eprosartan—Nausea—Propantheline—pancreatitis	0.00598	0.0121	CcSEcCtD
Eprosartan—AGTR1—Arf6 signaling events—HGF—pancreatitis	0.00594	0.0205	CbGpPWpGaD
Eprosartan—AGTR1—Peptide GPCRs—TACR1—pancreatitis	0.00589	0.0203	CbGpPWpGaD
Eprosartan—AGTR1—Peptide GPCRs—CCKAR—pancreatitis	0.0058	0.02	CbGpPWpGaD
Eprosartan—Angioedema—Hyoscyamine—pancreatitis	0.00577	0.0117	CcSEcCtD
Eprosartan—Vertigo—Hyoscyamine—pancreatitis	0.00567	0.0115	CcSEcCtD
Eprosartan—Syncope—Hyoscyamine—pancreatitis	0.00566	0.0114	CcSEcCtD
Eprosartan—CYP2C9—digestive system—pancreatitis	0.00559	0.026	CbGeAlD
Eprosartan—Palpitations—Hyoscyamine—pancreatitis	0.00558	0.0113	CcSEcCtD
Eprosartan—Loss of consciousness—Hyoscyamine—pancreatitis	0.00555	0.0112	CcSEcCtD
Eprosartan—Chest pain—Hyoscyamine—pancreatitis	0.00537	0.0109	CcSEcCtD
Eprosartan—Anxiety—Hyoscyamine—pancreatitis	0.00536	0.0108	CcSEcCtD
Eprosartan—CYP2C9—blood—pancreatitis	0.00533	0.0248	CbGeAlD
Eprosartan—Dry mouth—Hyoscyamine—pancreatitis	0.00526	0.0106	CcSEcCtD
Eprosartan—Shock—Hyoscyamine—pancreatitis	0.00507	0.0102	CcSEcCtD
Eprosartan—Tachycardia—Hyoscyamine—pancreatitis	0.00503	0.0102	CcSEcCtD
Eprosartan—Hyperhidrosis—Hyoscyamine—pancreatitis	0.00498	0.0101	CcSEcCtD
Eprosartan—AGTR1—Allograft Rejection—IL13—pancreatitis	0.00495	0.0171	CbGpPWpGaD
Eprosartan—Hypotension—Hyoscyamine—pancreatitis	0.00481	0.00973	CcSEcCtD
Eprosartan—AGTR1—Arf6 signaling events—MET—pancreatitis	0.00469	0.0162	CbGpPWpGaD
Eprosartan—Insomnia—Hyoscyamine—pancreatitis	0.00466	0.00941	CcSEcCtD
Eprosartan—Dyspnoea—Hyoscyamine—pancreatitis	0.00459	0.00928	CcSEcCtD
Eprosartan—Somnolence—Hyoscyamine—pancreatitis	0.00458	0.00925	CcSEcCtD
Eprosartan—Dyspepsia—Hyoscyamine—pancreatitis	0.00454	0.00916	CcSEcCtD
Eprosartan—Fatigue—Hyoscyamine—pancreatitis	0.00444	0.00897	CcSEcCtD
Eprosartan—Pain—Hyoscyamine—pancreatitis	0.00441	0.0089	CcSEcCtD
Eprosartan—Constipation—Hyoscyamine—pancreatitis	0.00441	0.0089	CcSEcCtD
Eprosartan—AGTR1—ACE Inhibitor Pathway—TGFB1—pancreatitis	0.00432	0.0149	CbGpPWpGaD
Eprosartan—AGTR1—Peptide GPCRs—BDKRB2—pancreatitis	0.00431	0.0149	CbGpPWpGaD
Eprosartan—Feeling abnormal—Hyoscyamine—pancreatitis	0.00425	0.00858	CcSEcCtD
Eprosartan—Gastrointestinal pain—Hyoscyamine—pancreatitis	0.00421	0.00851	CcSEcCtD
Eprosartan—Urticaria—Hyoscyamine—pancreatitis	0.00409	0.00827	CcSEcCtD
Eprosartan—Abdominal pain—Hyoscyamine—pancreatitis	0.00407	0.00823	CcSEcCtD
Eprosartan—Body temperature increased—Hyoscyamine—pancreatitis	0.00407	0.00823	CcSEcCtD
Eprosartan—AGTR1—Peptide ligand-binding receptors—PPY—pancreatitis	0.00386	0.0133	CbGpPWpGaD
Eprosartan—Hypersensitivity—Hyoscyamine—pancreatitis	0.0038	0.00767	CcSEcCtD
Eprosartan—Asthenia—Hyoscyamine—pancreatitis	0.0037	0.00747	CcSEcCtD
Eprosartan—Pruritus—Hyoscyamine—pancreatitis	0.00365	0.00736	CcSEcCtD
Eprosartan—CYP2C9—Cytochrome P450 - arranged by substrate type—FDX1—pancreatitis	0.00358	0.0123	CbGpPWpGaD
Eprosartan—Diarrhoea—Hyoscyamine—pancreatitis	0.00353	0.00712	CcSEcCtD
Eprosartan—AGTR1—Allograft Rejection—HLA-DQA1—pancreatitis	0.00351	0.0121	CbGpPWpGaD
Eprosartan—Dizziness—Hyoscyamine—pancreatitis	0.00341	0.00688	CcSEcCtD
Eprosartan—AGTR1—Arf6 trafficking events—INS—pancreatitis	0.0033	0.0114	CbGpPWpGaD
Eprosartan—Vomiting—Hyoscyamine—pancreatitis	0.00328	0.00662	CcSEcCtD
Eprosartan—Rash—Hyoscyamine—pancreatitis	0.00325	0.00656	CcSEcCtD
Eprosartan—Dermatitis—Hyoscyamine—pancreatitis	0.00325	0.00656	CcSEcCtD
Eprosartan—Headache—Hyoscyamine—pancreatitis	0.00323	0.00652	CcSEcCtD
Eprosartan—AGTR1—Allograft Rejection—IL10—pancreatitis	0.0031	0.0107	CbGpPWpGaD
Eprosartan—Nausea—Hyoscyamine—pancreatitis	0.00306	0.00618	CcSEcCtD
Eprosartan—AGTR1—G alpha (q) signalling events—CASR—pancreatitis	0.00302	0.0104	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CX3CL1—pancreatitis	0.00292	0.0101	CbGpPWpGaD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—FDX1—pancreatitis	0.0029	0.01	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—CCK—pancreatitis	0.00288	0.00994	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CCK—pancreatitis	0.00284	0.00981	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—TACR1—pancreatitis	0.00281	0.00968	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—TACR1—pancreatitis	0.00277	0.00956	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—CCKAR—pancreatitis	0.00276	0.00953	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CCKAR—pancreatitis	0.00273	0.00941	CbGpPWpGaD
Eprosartan—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatitis	0.00272	0.00939	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—CASR—pancreatitis	0.0027	0.00932	CbGpPWpGaD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—ADH4—pancreatitis	0.0027	0.00931	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—PPY—pancreatitis	0.00259	0.00893	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—CCK—pancreatitis	0.00258	0.00889	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TACR1—pancreatitis	0.00251	0.00866	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—HLA-DRB1—pancreatitis	0.00249	0.00861	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—CCKAR—pancreatitis	0.00247	0.00852	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—HSP90AB1—pancreatitis	0.00234	0.00809	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—MTNR1B—pancreatitis	0.00223	0.00768	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CNR2—pancreatitis	0.00217	0.00749	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—SST—pancreatitis	0.00215	0.00744	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCKAR—pancreatitis	0.00213	0.00736	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—BDKRB2—pancreatitis	0.00205	0.00708	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—BDKRB2—pancreatitis	0.00203	0.00699	CbGpPWpGaD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—ADH1B—pancreatitis	0.00201	0.00694	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—SERPINA1—pancreatitis	0.00201	0.00693	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—PPY—pancreatitis	0.00197	0.0068	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CX3CL1—pancreatitis	0.00196	0.00677	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—GCG—pancreatitis	0.00195	0.00671	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—pancreatitis	0.00191	0.00658	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCK—pancreatitis	0.00191	0.00658	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—KNG1—pancreatitis	0.00187	0.00644	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CNR2—pancreatitis	0.00186	0.00641	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—TACR1—pancreatitis	0.00186	0.00641	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—KNG1—pancreatitis	0.00184	0.00636	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—BDKRB2—pancreatitis	0.00184	0.00633	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCKAR—pancreatitis	0.00183	0.00631	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GCG—pancreatitis	0.00174	0.006	CbGpPWpGaD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—pancreatitis	0.0017	0.00587	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—CXCL8—pancreatitis	0.00169	0.00585	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—pancreatitis	0.00167	0.00576	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IL1B—pancreatitis	0.00163	0.00561	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—CASP3—pancreatitis	0.00162	0.0056	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—BDKRB2—pancreatitis	0.00159	0.00547	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CNR1—pancreatitis	0.00156	0.00537	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CCL5—pancreatitis	0.00154	0.00532	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—FDX1—pancreatitis	0.00154	0.00532	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—SCT—pancreatitis	0.00152	0.00525	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CASR—pancreatitis	0.00152	0.00525	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CX3CL1—pancreatitis	0.00149	0.00515	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CCK—pancreatitis	0.00145	0.00501	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—MTNR1B—pancreatitis	0.00145	0.00501	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—SST—pancreatitis	0.00145	0.00499	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—EGR1—pancreatitis	0.00143	0.00495	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—ADH4—pancreatitis	0.00143	0.00494	CbGpPWpGaD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—ALDH2—pancreatitis	0.00142	0.00489	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CNR2—pancreatitis	0.00142	0.00488	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—TACR1—pancreatitis	0.00142	0.00488	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—CFTR—pancreatitis	0.0014	0.00483	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CCKAR—pancreatitis	0.00139	0.00481	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—HTR2A—pancreatitis	0.00138	0.00475	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—BDKRB2—pancreatitis	0.00136	0.00469	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CNR1—pancreatitis	0.00133	0.0046	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—TGFB1—pancreatitis	0.00126	0.00436	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—KNG1—pancreatitis	0.00124	0.00427	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—pancreatitis	0.00123	0.00425	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—PTHLH—pancreatitis	0.0012	0.00415	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—SMO—pancreatitis	0.0012	0.00415	CbGpPWpGaD
Eprosartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatitis	0.00119	0.00412	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—HGF—pancreatitis	0.00118	0.00408	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—TNF—pancreatitis	0.00118	0.00407	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—PPY—pancreatitis	0.00111	0.00384	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—SST—pancreatitis	0.0011	0.0038	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—ADH1B—pancreatitis	0.00107	0.00369	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2A—pancreatitis	0.00106	0.00367	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CCL2—pancreatitis	0.00106	0.00366	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—BDKRB2—pancreatitis	0.00103	0.00357	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL5—pancreatitis	0.00103	0.00357	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CNR1—pancreatitis	0.00102	0.00351	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PPY—pancreatitis	0.00101	0.00349	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—GCG—pancreatitis	0.000981	0.00339	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—KNG1—pancreatitis	0.000941	0.00325	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—pancreatitis	0.000911	0.00315	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—SCT—pancreatitis	0.00086	0.00297	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CASR—pancreatitis	0.00086	0.00297	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CXCL8—pancreatitis	0.000839	0.0029	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—TRPV1—pancreatitis	0.000825	0.00285	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CCK—pancreatitis	0.000821	0.00283	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—MTNR1B—pancreatitis	0.000821	0.00283	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—TACR1—pancreatitis	0.0008	0.00276	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CNR2—pancreatitis	0.0008	0.00276	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CCL5—pancreatitis	0.000787	0.00272	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CCKAR—pancreatitis	0.000787	0.00272	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—SCT—pancreatitis	0.000781	0.0027	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CASR—pancreatitis	0.000781	0.0027	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CX3CL1—pancreatitis	0.000766	0.00264	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—ALDH2—pancreatitis	0.000752	0.0026	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCK—pancreatitis	0.000745	0.00257	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—MTNR1B—pancreatitis	0.000745	0.00257	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CNR2—pancreatitis	0.000726	0.00251	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—TACR1—pancreatitis	0.000726	0.00251	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCKAR—pancreatitis	0.000715	0.00247	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—pancreatitis	0.000712	0.00246	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—HTR2A—pancreatitis	0.000694	0.0024	CbGpPWpGaD
Eprosartan—CYP2C9—Arachidonic acid metabolism—PTGS2—pancreatitis	0.00069	0.00238	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—PTHLH—pancreatitis	0.00068	0.00235	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PNLIP—pancreatitis	0.000666	0.0023	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—SST—pancreatitis	0.000622	0.00215	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PTHLH—pancreatitis	0.000618	0.00213	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—SMO—pancreatitis	0.000618	0.00213	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—pancreatitis	0.00061	0.00211	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PPY—pancreatitis	0.000597	0.00206	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—FDX1—pancreatitis	0.000592	0.00204	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PPP3CA—pancreatitis	0.000589	0.00203	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—BDKRB2—pancreatitis	0.000585	0.00202	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CNR1—pancreatitis	0.000574	0.00198	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—SST—pancreatitis	0.000565	0.00195	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatitis	0.000563	0.00194	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—GCG—pancreatitis	0.000554	0.00191	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CCL2—pancreatitis	0.000542	0.00187	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—KNG1—pancreatitis	0.000532	0.00184	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—BDKRB2—pancreatitis	0.000531	0.00183	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatitis	0.000525	0.00181	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CNR1—pancreatitis	0.000521	0.0018	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—GCG—pancreatitis	0.000503	0.00174	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PNLIP—pancreatitis	0.00049	0.00169	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—KNG1—pancreatitis	0.000483	0.00167	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—TGFB1—pancreatitis	0.000482	0.00166	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—FGG—pancreatitis	0.000462	0.00159	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SCT—pancreatitis	0.000462	0.00159	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CASR—pancreatitis	0.000462	0.00159	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CX3CL1—pancreatitis	0.000453	0.00156	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatitis	0.000446	0.00154	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CCL5—pancreatitis	0.000445	0.00154	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MTNR1B—pancreatitis	0.00044	0.00152	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCK—pancreatitis	0.00044	0.00152	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—A2M—pancreatitis	0.000429	0.00148	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CNR2—pancreatitis	0.000429	0.00148	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TACR1—pancreatitis	0.000429	0.00148	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CXCL8—pancreatitis	0.000429	0.00148	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—pancreatitis	0.000427	0.00147	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCKAR—pancreatitis	0.000422	0.00146	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCL5—pancreatitis	0.000404	0.00139	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—FGA—pancreatitis	0.000392	0.00135	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—HTR2A—pancreatitis	0.000392	0.00135	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PTHLH—pancreatitis	0.000365	0.00126	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SMO—pancreatitis	0.000365	0.00126	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—FGB—pancreatitis	0.000357	0.00123	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—HTR2A—pancreatitis	0.000356	0.00123	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PPP3CA—pancreatitis	0.000348	0.0012	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SST—pancreatitis	0.000334	0.00115	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—DUSP6—pancreatitis	0.000331	0.00114	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G1B—pancreatitis	0.000327	0.00113	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—A2M—pancreatitis	0.000316	0.00109	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—BDKRB2—pancreatitis	0.000314	0.00108	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CNR1—pancreatitis	0.000308	0.00106	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CTRB2—pancreatitis	0.000304	0.00105	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GCG—pancreatitis	0.000297	0.00103	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—KNG1—pancreatitis	0.000285	0.000985	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCL2—pancreatitis	0.000278	0.000961	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—FDX1—pancreatitis	0.000263	0.000909	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PDGFA—pancreatitis	0.000262	0.000906	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ADH4—pancreatitis	0.000245	0.000845	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—ALB—pancreatitis	0.000244	0.000843	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CXCL8—pancreatitis	0.000242	0.000836	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCL5—pancreatitis	0.000239	0.000824	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—LPL—pancreatitis	0.000233	0.000805	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PRSS1—pancreatitis	0.00023	0.000795	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SPP1—pancreatitis	0.000221	0.000763	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CXCL8—pancreatitis	0.00022	0.000759	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PRSS3—pancreatitis	0.000218	0.000753	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PNLIP—pancreatitis	0.000218	0.000753	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HTR2A—pancreatitis	0.00021	0.000726	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—XDH—pancreatitis	0.000196	0.000676	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—LEP—pancreatitis	0.000196	0.000675	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ADH1B—pancreatitis	0.000183	0.00063	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—NRAS—pancreatitis	0.000177	0.000609	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—LPL—pancreatitis	0.000172	0.000593	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—INS—pancreatitis	0.000167	0.000577	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCL2—pancreatitis	0.000164	0.000567	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—KRAS—pancreatitis	0.000152	0.000524	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PLA2G1B—pancreatitis	0.000146	0.000503	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—A2M—pancreatitis	0.000141	0.000485	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MDM2—pancreatitis	0.000139	0.00048	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CXCL8—pancreatitis	0.00013	0.000449	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—HRAS—pancreatitis	0.000129	0.000446	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ALDH2—pancreatitis	0.000129	0.000444	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	0.000125	0.000433	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CASP3—pancreatitis	0.000124	0.000429	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—IL6—pancreatitis	0.000124	0.000427	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—pancreatitis	0.000113	0.000389	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NRAS—pancreatitis	0.000104	0.00036	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	9.87e-05	0.000341	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GCG—pancreatitis	9.75e-05	0.000337	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TGFB1—pancreatitis	9.69e-05	0.000334	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—KRAS—pancreatitis	8.98e-05	0.00031	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—LPL—pancreatitis	7.65e-05	0.000264	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HRAS—pancreatitis	7.63e-05	0.000263	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IL6—pancreatitis	7.3e-05	0.000252	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PPARG—pancreatitis	5.59e-05	0.000193	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—INS—pancreatitis	5.48e-05	0.000189	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ALB—pancreatitis	5.02e-05	0.000173	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PTGS2—pancreatitis	4.39e-05	0.000152	CbGpPWpGaD
